Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

FDA approves Pfizer's leukemia drug
FDA approves Pfizer's leukemia drug
(Reuters) - The U.
Novartis names drugs chief as CEO to deliver return to growth
Novartis names drugs chief as CEO to deliver return to growth
ZURICH (Reuters) - Novartis (NOVN.
Japan's Daiichi Sankyo denies 2016 takeover bid by AstraZeneca
Japan's Daiichi Sankyo denies 2016 takeover bid by AstraZeneca
TOKYO (Reuters) - Japanese drugmaker Daiichi Sankyo denied on Thursday it received a takeover bid last year from Britain’s AstraZeneca, following speculation that sent its share price soarin...
FDA approves Pfizer's leukemia drug
FDA approves Pfizer's leukemia drug
(Reuters) - The U.
Heptares doses first subject in Alzheimer’s drug trial
Heptares doses first subject in Alzheimer’s drug trial
London, UK-based Heptares Therapeutics says the first healthy subject has now been dosed with its first-in-class, selective muscarinic M4 receptor agonist HTL0016878 in a Phase I clinical study.
India's Mahendra Chemicals API plant put on FDA import alert list by Eric Palmer
India's Mahendra Chemicals API plant put on FDA import alert list by Eric Palmer
The FDA issued a warning letter to India’s Mahendra Chemicals after finding a data and document disaster at its API plant in Ahmedabad.
Mylan and Biocon Herceptin biosimilar delayed by FDA for 3 months
Mylan and Biocon Herceptin biosimilar delayed by FDA for 3 months
Mylan and Biocon, which have had trouble getting to the regulatory finish line in Europe with their biosimilar of Roche’s blockbuster Herceptin because of manufacturing concerns, now face a three-mo...
FDA approves Chemo Research's treatment for Chagas disease
FDA approves Chemo Research's treatment for Chagas disease
WASHINGTON — Earlier this week the U.
Eli Lilly to refile RA remedy to FDA
Eli Lilly to refile RA remedy to FDA
INDIANAPOLIS — Eli Lilly and Incyte Corporation on Wednesday announced that, after discussions with the U.
The Medicines Company Announces FDA Approval of VABOMERE™ (meropenem and vaborbactam)
The Medicines Company Announces FDA Approval of VABOMERE™ (meropenem and vaborbactam)
PARSIPPANY, N.
FDA approval brings first gene therapy to the United States
FDA approval brings first gene therapy to the United States
The U.
AstraZeneca strikes $400 million Parkinson's drug deal with Takeda
AstraZeneca strikes $400 million Parkinson's drug deal with Takeda
LONDON (Reuters) - AstraZeneca is to receive up to $400 million from Takeda Pharmaceutical after striking a deal for the Japanese company to co-develop an early-stage medicine for Parkinson’...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand